Breaking News

Thermo Fisher Scientific Completes PPD Acquisition

With the addition of PPD, Thermo Fisher will offer a comprehensive suite of services across the clinical development spectrum.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific Inc. has completed its acquisition of PPD, Inc., a global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.   “We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. “Expanding our value proposition for our biotech and pharmaceutical customers with the addition of PPD&#8217...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters